Literature DB >> 28879648

Is there any difference in acromegaly and other chronic disease in quality of life and psychiatric morbidity?

Dorota Maria Szcześniak1, Aleksandra Jawiarczyk-Przybyłowska, Łukasz Matusiak, Anna Bolanowska, Julian Maciaszek, Małgorzata Siemińska, Joanna Rymaszewska, Marek Bolanowski.   

Abstract

INTRODUCTION: The study aimed to evaluate the psychological profile of patients with acromegaly in comparison to other chronic diseases such as non-functioning pituitary adenomas, Cushing disease, and plaque psoriasis, and to a healthy control group.
MATERIAL AND METHODS: A total sample of 153 participants in clinical groups underwent a cross-sectional assessment including the quality of life (AcroQoL, WHOQoL-BREF), psychiatric morbidity (GHQ-28), and the acceptance of illness (AIS), as well as 65 participants in the healthy control group.
RESULTS: The whole study sample had a predominance of urban married females (61%) with medium level of education (41%). Patients with acromegaly were diagnosed significantly later than patients from other clinical groups, after the onset of the first symptoms. Acromegaly was related to the presence of more symptoms of anxiety and insomnia, and poorer social relationships compared with the general population but not more than in other chronic diseases. A better quality of life score in all domains of WHOQoL-BREF was associated with a better score on the acceptance of illness scale and lower scores on GHQ-28.
CONCLUSIONS: Psychiatric morbidity, mainly anxiety and insomnia, occurs in 50% of patients with acromegaly. However, the psychological wellbeing and mood seem to be related to other factors such as the acceptance of the illness. Thus, concerning the diagnosis, treatment, and monitoring of acromegaly an interdisciplinary approach, taking into account psychological and psychiatric consultation, is needed.

Entities:  

Keywords:  acromegaly; chronic disease; psychopathology; quality of life

Year:  2017        PMID: 28879648     DOI: 10.5603/EP.a2017.0044

Source DB:  PubMed          Journal:  Endokrynol Pol        ISSN: 0423-104X            Impact factor:   1.582


  5 in total

1.  Executive functioning and quality of life in acromegaly.

Authors:  Emilia Solomon; Dumitru Brănișteanu; Andrei Dumbravă; Radu Gheorghe Solomon; Lorànt Kiss; Mihai Glod; Cristina Preda
Journal:  Psychol Res Behav Manag       Date:  2019-01-03

2.  Validation of Acromegaly Quality of Life Questionnaire (AcroQoL) for the Iranian population.

Authors:  Mina Danaei; Leyla Bahadorizadeh; Afsaneh Dehnad; Shirin Mohamadzadeh; Nahid Hashemi-Madani; Mohammad E Khamseh
Journal:  BMC Psychol       Date:  2022-03-14

3.  Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life.

Authors:  Biagio Cangiano; Emanuele Giusti; Letizia Maria Fatti; Massimo Scacchi; Caterina Premoli; Davide Soranna; Giovanni Vitale; Silvia Grottoli; Valeria Cambria; Giovanna Mantovani; Roberta Mungari; Pietro Maffei; Francesca Dassie; Antonella Giampietro; Sabrina Chiloiro; Maria Laura Tanda; Silvia Ippolito; Salvatore Cannavò; Marta Ragonese; Antonella Zambon; Luca Persani
Journal:  Endocrine       Date:  2022-07-02       Impact factor: 3.925

4.  Importance of Illness Acceptance Among Other Factors Affecting Quality of Life in Acromegaly.

Authors:  Aleksandra Jawiarczyk-Przybyłowska; Dorota Szcześniak; Marta Ciułkowicz; Marek Bolanowski; Joanna Rymaszewska
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-14       Impact factor: 5.555

Review 5.  Questionnaire and tools: clinical powerful instrument in acromegaly diagnosis and management.

Authors:  P Maffei; F Dassie; S Camerini; A Wennberg; M Adriani; B Martin; R Vettor
Journal:  J Endocrinol Invest       Date:  2022-03-23       Impact factor: 5.467

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.